We are highly committed to restoring and improving the lives of patients by developing novel compounds into innovative new drugs through rigorous global clinical development process.

  • Development-focused Business Operations

    Initiation and oversight of efficient global clinical development

    Focus on First-in-class & Best-in-class candidates

    Utilization of our global open innovation networks

  • Research Operations for Discovering Innovative New Drugs

    Research on next generation Pellino inhibitors

    Application of new technologies such as DEL

    Discovery of novel drug candidates